TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3883739

Group type: EXPERIMENTAL
Intervention: Propranolol-Verapamil (P-V)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Propranolol-Nifedipine (P-N)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Propranolol-Diltiazem (P-D)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 19
Study: 29613975

Group type: EXPERIMENTAL
Intervention: Antibiotic therapy for late-onset sepsis
Number of subjects: 408
Study: 29152839

Group type: EXPERIMENTAL
Intervention: Gastric bypass surgery (GB)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control subjects (CN)
Number of subjects: 19
Study: 27128159

Group type: EXPERIMENTAL
Intervention: Media literacy education
Number of subjects: 472

Group type: EXPERIMENTAL
Intervention: Need for cognition
Number of subjects: 472

Group type: EXPERIMENTAL
Intervention: Need for affect
Number of subjects: 472
Study: 24023271

Group type: EXPERIMENTAL
Intervention: Individualized action plans connecting patients to patient-assistance programs
Number of subjects: 374

Group type: COMPARATOR
Intervention: Usual care (informational pamphlet)
Number of subjects: 374
Study: 22004699

Group type: EXPERIMENTAL
Intervention: Type one tympanoplasty with anterior tagging
Number of subjects: 60

Group type: COMPARATOR
Intervention: Type one tympanoplasty without anterior tagging
Number of subjects: 60
Study: 20461009

Group type: EXPERIMENTAL
Intervention: Butyrate enema (100 mmol/l butyrate, 60 ml rectal enema, once daily for 2 weeks in healthy volunteers and 3 weeks in UC patients)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo enema (60 ml rectal enema, once daily for 2 weeks in healthy volunteers and 3 weeks in UC patients)
Number of subjects: 51
Study: 17606562

Group type: EXPERIMENTAL
Intervention: Clinical-intervention-plus-home-intervention group
Number of subjects: 130

Group type: COMPARATOR
Intervention: Clinical-intervention-only group
Number of subjects: 130

Group type: COMPARATOR
Intervention: Adequate-growth group
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 130
Study: 16123472

Group type: EXPERIMENTAL
Intervention: nateglinide/metformin
Number of subjects: 428

Group type: COMPARATOR
Intervention: glyburide/metformin
Number of subjects: 428
Study: 12373613

Group type: EXPERIMENTAL
Intervention: Weekly supplementation with iron (60 mg as ferrous sulphate) and folic acid (250 micro g) (n=121)
Number of subjects: 366

Group type: EXPERIMENTAL
Intervention: Weekly supplementation with vitamin A (2400 RE) in addition to iron and folic acid (n=122)
Number of subjects: 366

Group type: COMPARATOR
Intervention: Daily iron supplementation group (n=123)
Number of subjects: 366
Study: 11223662

Group type: EXPERIMENTAL
Intervention: Echo-enhanced transcranial color-coded duplexsonography (TCCD)
Number of subjects: 30
Study: 9599193

Group type: EXPERIMENTAL
Intervention: Antilymphocyte antibodies (induction therapy)
Number of subjects: 628
Study: 7827444

Group type: EXPERIMENTAL
Intervention: Subzonal insemination (SUZI)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Microdroplet IVF
Number of subjects: 89

Group type: COMPARATOR
Intervention: Standard IVF
Number of subjects: 89
Study: 3280773

Group type: EXPERIMENTAL
Intervention: Prophylactic furosemide (1 mg/kg every 12 hours for four doses beginning at 24 hours of age)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prophylactic furosemide
Number of subjects: 0

Group type: COMPARATOR
Intervention: prn use of furosemide
Number of subjects: 0
Study: 31895407

Group type: EXPERIMENTAL
Intervention: Pembrolizumab therapy (200 mg every 3 weeks for a total of 18 doses)
Number of subjects: 1019

Group type: EXPERIMENTAL
Intervention: Pembrolizumab therapy (with irAE)
Number of subjects: 1019

Group type: EXPERIMENTAL
Intervention: Pembrolizumab therapy (after onset of irAE)
Number of subjects: 1019

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1019

Group type: COMPARATOR
Intervention: Placebo (before onset of irAE)
Number of subjects: 1019
Study: 30180402

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (20-30 mg/(kg·d))
Number of subjects: 62

Group type: COMPARATOR
Intervention: Cyclosporine A (3-5 mg/(kg·d))
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil
Number of subjects: 62

Group type: COMPARATOR
Intervention: Cyclosporine A
Number of subjects: 62
Study: 28974902

Group type: EXPERIMENTAL
Intervention: Uncut Roux‐en‐Y
Number of subjects: 158

Group type: COMPARATOR
Intervention: Billroth II
Number of subjects: 158
Study: 26551304

Group type: EXPERIMENTAL
Intervention: Clopidogrel + Aspirin (n=84)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Placebo + Aspirin (n=87)
Number of subjects: 171
Study: 23638764

Group type: EXPERIMENTAL
Intervention: Listerine(®) Total Care
Number of subjects: 15

Group type: COMPARATOR
Intervention: 22% hydro‐alcohol solution (negative control)
Number of subjects: 15

Group type: COMPARATOR
Intervention: 0.2% chlorhexidine solution (positive control)
Number of subjects: 15
Study: 21564106

Group type: EXPERIMENTAL
Intervention: New blood transfusion (less than 14 days old)
Number of subjects: 444

Group type: COMPARATOR
Intervention: Old blood transfusion (more than 14 days old)
Number of subjects: 444

Group type: COMPARATOR
Intervention: Any old blood transfusion
Number of subjects: 444

Group type: COMPARATOR
Intervention: Old blood transfusion (1 unit)
Number of subjects: 444

Group type: EXPERIMENTAL
Intervention: Each 1-day increase in storage of RBCs
Number of subjects: 444
Study: 19177860

Group type: EXPERIMENTAL
Intervention: Supplemental oxygen (40% inspired oxygen fraction through a face mask)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Room air
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Supplemental oxygen
Number of subjects: 130
Study: 17367032

Group type: EXPERIMENTAL
Intervention: Brushtox
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Periogard
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Experimental solution (Cosmocil CQa and Myacide pharma BPa-based)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Sterile tap water (control)
Number of subjects: 52

Group type: COMPARATOR
Intervention: In vitro (Periogard, Experimental solution, Brushtox, Sterile tap water)
Number of subjects: 52
Study: 14622666

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control (placebo TENS and pharmacologic analgesia alone)
Number of subjects: 33
Study: 11303325

Group type: EXPERIMENTAL
Intervention: 75 mg acetylsalicylic acid (aspirin) daily
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: 150 mg acetylsalicylic acid (aspirin) daily
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: 75 mg and 150 mg acetylsalicylic acid (aspirin) daily
Number of subjects: 53
Study: 8972367

Group type: EXPERIMENTAL
Intervention: Test group with trephine sizing based on preoperative videokeratoscopy
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Test group
Number of subjects: 18
Study: 1463410

Group type: EXPERIMENTAL
Intervention: Diode laser photocoagulation
Number of subjects: 32

Group type: COMPARATOR
Intervention: Cryotherapy
Number of subjects: 32
Study: 31183985

Group type: EXPERIMENTAL
Intervention: Amorphous solid dispersion formulation
Number of subjects: 12

Group type: COMPARATOR
Intervention: Nanocrystal formulation
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Breakfast consumption (low-fat and high-fat)
Number of subjects: 12
Study: 30517649

Group type: EXPERIMENTAL
Intervention: EHR imaging order requisition indications
Number of subjects: 315

Group type: EXPERIMENTAL
Intervention: Discrepancy between clinical information in requisitions and provider notes
Number of subjects: 315

Group type: EXPERIMENTAL
Intervention: Kappa agreement among radiologists
Number of subjects: 315
Study: 26597930

Group type: EXPERIMENTAL
Intervention: Real rTMS (n = 12)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham TMS (n = 8)
Number of subjects: 20
Study: 25244489

Group type: EXPERIMENTAL
Intervention: Cognitive training
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cognitive training + Aerobic exercise
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aerobic exercise
Number of subjects: 0
Study: 22918011

Group type: EXPERIMENTAL
Intervention: Butorphanol 1 mg intramuscular
Number of subjects: 40

Group type: COMPARATOR
Intervention: Tramadol 50 mg intramuscular
Number of subjects: 40
Study: 21196805

Group type: EXPERIMENTAL
Intervention: Art-based leadership program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional leadership program
Number of subjects: 0
Study: 18081170

Group type: EXPERIMENTAL
Intervention: Clerkship structure with an academic attending, a third-year pediatric resident, and 4 third-year medical students, but no interns.
Number of subjects: 203

Group type: COMPARATOR
Intervention: Traditional services (control group)
Number of subjects: 203
Study: 17162861

Group type: EXPERIMENTAL
Intervention: Cyanoacrylate tissue adhesive (CTA)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Suture
Number of subjects: 27
Study: 11870337

Group type: EXPERIMENTAL
Intervention: Vibrant Soundbridge System (VSB)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Acoustic hearing aid
Number of subjects: 53
Study: 10634122

Group type: EXPERIMENTAL
Intervention: Multidisciplinary approach (joint home visits)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Traditional approach (solo visits)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Both groups (joint home visits and solo visits)
Number of subjects: 47
Study: 8610779

Group type: EXPERIMENTAL
Intervention: High-dose oxytocin
Number of subjects: 310

Group type: COMPARATOR
Intervention: Low-dose oxytocin
Number of subjects: 310
Study: 2125428

Group type: EXPERIMENTAL
Intervention: Fentanyl and diazepam (n = 30)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Fentanyl alone (n = 31)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 61
Study: 6252835

Group type: EXPERIMENTAL
Intervention: Mecillinam added to cefazolin and carbenicillin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo added to cefazolin and carbenicillin
Number of subjects: 0
Study: 30801481

Group type: EXPERIMENTAL
Intervention: Amifampridine phosphate (30-80 mg/d divided into 3 or 4 doses daily)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 28927270

Group type: EXPERIMENTAL
Intervention: Orange juice
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Water
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Glucose (isocaloric beverage)
Number of subjects: 12
Study: 26097441

Group type: EXPERIMENTAL
Intervention: L-citrulline (0.3 mM)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: GSH (1 mM)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: L-citrulline (500 mg/kg/day) + GSH (50 mg/kg/day)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: L-citrulline (2 g/day) + GSH (200 mg/day)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Cellulose placebo (2.52 g/day)
Number of subjects: 3
Study: 24862633

Group type: EXPERIMENTAL
Intervention: Robot-assisted laparoscopic radical cystectomy (RARC)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Open radical cystectomy (ORC)
Number of subjects: 40
Study: 22401726

Group type: EXPERIMENTAL
Intervention: Psychosomatic approach program (10 sessions, one/week for 2 hours and 15 minutes, with phone calls between sessions)
Number of subjects: 184

Group type: COMPARATOR
Intervention: Usual program of the health center (8-10 weekly sessions of 2 hours, no phone calls)
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Psychosomatic approach program
Number of subjects: 184

Group type: COMPARATOR
Intervention: Usual program of the health center
Number of subjects: 184
Study: 19733719

Group type: EXPERIMENTAL
Intervention: Lovastatin therapy
Number of subjects: 2928
Study: 17419798

Group type: EXPERIMENTAL
Intervention: Nutritional intervention including a nutritional journal and protein-enriched meals for at least four days postoperatively, plus at least two nutritional and protein drinks served each day during hospitalization.
Number of subjects: 157

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 157
Study: 14747185

Group type: EXPERIMENTAL
Intervention: Hysterectomy
Number of subjects: 236

Group type: COMPARATOR
Intervention: LNG-IUS
Number of subjects: 236
Study: 11499327

Group type: EXPERIMENTAL
Intervention: Tazarotene 0.1% gel applied on alternate days for 15 weeks
Number of subjects: 164

Group type: COMPARATOR
Intervention: Adapalene 0.1% gel applied once daily for 15 weeks
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Tazarotene 0.1% gel applied on alternate days
Number of subjects: 164

Group type: COMPARATOR
Intervention: Adapalene 0.1% gel applied once daily
Number of subjects: 164
Study: 10212375

Group type: EXPERIMENTAL
Intervention: Visomat OZ2 (upper arm)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Omron R3 (wrist)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Sphygmomanometer (control)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Oscillometric blood pressure monitors (upper arm and wrist)
Number of subjects: 85
Study: 8163757

Group type: EXPERIMENTAL
Intervention: Intravenous flecainide (2 mg/kg for 10 min and continuous perfusion of 1.5 mg/kg for 1 h)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Intravenous verapamil (0.15 mg/kg for 5 min and continuous perfusion of 0.005 mg/kg/min for 1 h)
Number of subjects: 30
Study: 3147191

Group type: EXPERIMENTAL
Intervention: 58 different fat-modified diets
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: fat-modified diets
Number of subjects: 130
Study: 31747095

Group type: EXPERIMENTAL
Intervention: DCEAS+BA
Number of subjects: 91

Group type: COMPARATOR
Intervention: Minimum acupuncture stimulation (MAS)
Number of subjects: 91
Study: 30985642

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral intervention
Number of subjects: 55

Group type: COMPARATOR
Intervention: Waitlisted control group
Number of subjects: 55
Study: 28154256

Group type: EXPERIMENTAL
Intervention: Intrathecal dexmedetomidine (5 µg)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Intrathecal dexmedetomidine (2.5 µg)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Isotonic saline (control)
Number of subjects: 90
Study: 25886041

Group type: EXPERIMENTAL
Intervention: Closed-loop control of propofol
Number of subjects: 180

Group type: COMPARATOR
Intervention: Opened-loop control of propofol
Number of subjects: 180
Study: 24006857

Group type: EXPERIMENTAL
Intervention: Culturally adapted lifestyle intervention consisting of 10 group counseling sessions focusing on diet, physical activity, and behavioral change over 6 months, including gender-specific exercise sessions and counseling by a health coach community member.
Number of subjects: 308

Group type: COMPARATOR
Intervention: Control group receiving information about healthy lifestyle habits provided by the primary health care center.
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: Culturally adapted lifestyle intervention
Number of subjects: 308
Study: 21309858

Group type: EXPERIMENTAL
Intervention: Deprotenized bovine bone mineral (DBBM) and collagen barrier membranes (CM)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Mandibular blocks (control group)
Number of subjects: 22
Study: 19167814

Group type: EXPERIMENTAL
Intervention: Naltrexone (opioid antagonist)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 16388879

Group type: EXPERIMENTAL
Intervention: FMP1/AS02A vaccine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Imovax rabies vaccine
Number of subjects: 40
Study: 16366195

Group type: EXPERIMENTAL
Intervention: Itone drops (herbal eye drop)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Tears substitute (tears plus)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 11756319

Group type: EXPERIMENTAL
Intervention: Metformin (2,550 mg/day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Troglitazone (600 mg/day)
Number of subjects: 0
Study: 9640715

Group type: EXPERIMENTAL
Intervention: Tele-ophthalmology system initial assessment
Number of subjects: 100

Group type: COMPARATOR
Intervention: Face-to-face re-examination by the same ophthalmologist
Number of subjects: 100
Study: 8074951

Group type: EXPERIMENTAL
Intervention: Fissure sealants
Number of subjects: 4294
Study: 2572617

Group type: EXPERIMENTAL
Intervention: Loratadine (10 mg once daily)
Number of subjects: 317

Group type: EXPERIMENTAL
Intervention: Terfenadine (60 mg twice daily)
Number of subjects: 317

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 317
Study: 62266

Group type: EXPERIMENTAL
Intervention: Diet of polyunsaturated fats (linoleic acid)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Normal diet (Control)
Number of subjects: 19
Study: 29718901

Group type: EXPERIMENTAL
Intervention: Educational program consisting of 2 lectures, 1 video contact, group discussion of 5 myths about depression, posters, and brochure.
Number of subjects: 360

Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 360
Study: 27989865

Group type: EXPERIMENTAL
Intervention: Mechanical debridement + adjunct antimicrobial photodynamic therapy (MD + aPDT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Mechanical debridement alone (MD)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups (MD + aPDT and MD)
Number of subjects: 60
Study: 22909270

Group type: EXPERIMENTAL
Intervention: Magnesium bisglycinate chelate (300 mg per day)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study: 23232147

Group type: EXPERIMENTAL
Intervention: Optimal time of day testing (n = 21 for each age group)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Non-optimal time of day testing (n = 21 for each age group)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Optimal time of day testing
Number of subjects: 84
Study: 21906456

Group type: EXPERIMENTAL
Intervention: Remifentanil group (propofol at Ce of 6 μg/ml and remifentanil at Ce of 5 ng/ml)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (propofol at Ce of 6 μg/ml and rocuronium 0.8 mg/kg)
Number of subjects: 100
Study: 17604004

Group type: EXPERIMENTAL
Intervention: Pergolide (0.125 mg) before 1 Hz rTMS
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo before 1 Hz rTMS
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Pergolide (0.125 mg) before sham rTMS
Number of subjects: 9
Study: 16427122

Group type: EXPERIMENTAL
Intervention: Silane treatment (Monobond S, Ivoclar Vivadent)
Number of subjects: 54

Group type: COMPARATOR
Intervention: No silane treatment
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Coronal third of the root
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Medium third of the root
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Type of post (DT, FR, PP)
Number of subjects: 54
Study: 14765004

Group type: EXPERIMENTAL
Intervention: ADHD group
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 11
Study: 9894381

Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prophylactic antiarrhythmic therapy
Number of subjects: 0
Study: 7878805

Group type: EXPERIMENTAL
Intervention: Pentoxifylline (PTX) as an adjunct to cyclosporine-based immunosuppression
Number of subjects: 0
Study: 1973942

Group type: COMPARATOR
Intervention: Gepirone (5-30 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Gepirone (continuation therapy after 6 weeks of open therapy)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Gepirone
Number of subjects: 0
Study: 28070

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 50

Group type: COMPARATOR
Intervention: Pindolol
Number of subjects: 50
Study: 31523041

Group type: EXPERIMENTAL
Intervention: MRI scoring of bone marrow edema (BME)
Number of subjects: 441

Group type: EXPERIMENTAL
Intervention: MRI scoring of synovitis
Number of subjects: 441

Group type: EXPERIMENTAL
Intervention: MRI scoring of tenosynovitis
Number of subjects: 441

Group type: EXPERIMENTAL
Intervention: MRI scoring of erosions
Number of subjects: 441

Group type: EXPERIMENTAL
Intervention: Intrareader reliability for inflammatory MRI features
Number of subjects: 441

Group type: EXPERIMENTAL
Intervention: Change-score ICCs
Number of subjects: 441

Group type: EXPERIMENTAL
Intervention: Smallest detectable changes (SDC)
Number of subjects: 441

Group type: EXPERIMENTAL
Intervention: Reliability of MTP-joint MRI scores compared to MCP and wrist joints
Number of subjects: 441
Study: 28740085

Group type: EXPERIMENTAL
Intervention: Alcohol self‐dosing
Number of subjects: 88

Group type: COMPARATOR
Intervention: Sober condition
Number of subjects: 88
Study: 24577643

Group type: EXPERIMENTAL
Intervention: Incremental Shuttle Walk Test (ISWT)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Incremental Treadmill Test (ITMT)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 6-Minute Walk Test (6MWT)
Number of subjects: 16
Study: 22421693

Group type: EXPERIMENTAL
Intervention: Circumcision
Number of subjects: 526

Group type: COMPARATOR
Intervention: Uncircumcision
Number of subjects: 526
Study: 19439989

Group type: EXPERIMENTAL
Intervention: Acetylcysteine (5 g in 5% glucose in a final volume of 50 ml) administered intravenously during hemodialysis
Number of subjects: 24

Group type: COMPARATOR
Intervention: No acetylcysteine (placebo)
Number of subjects: 24
Study: 18158671

Group type: EXPERIMENTAL
Intervention: Role-playing during technical skills training
Number of subjects: 36

Group type: COMPARATOR
Intervention: No role-playing during technical skills training
Number of subjects: 36
Study: 15142699

Group type: EXPERIMENTAL
Intervention: Lengthening of the flexor retinaculum
Number of subjects: 26

Group type: COMPARATOR
Intervention: Simple division of the flexor retinaculum
Number of subjects: 26
Study: 11942713

Group type: EXPERIMENTAL
Intervention: Community changes facilitated by a community health initiative to prevent adolescent pregnancy
Number of subjects: 0
Study: 9617705

Group type: EXPERIMENTAL
Intervention: Magnetic stimulation of the brain and cervical and lumbar spinal roots
Number of subjects: 48
Study: 7714222

Group type: EXPERIMENTAL
Intervention: 15 mg/day buspirone
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Buspirone
Number of subjects: 44
Study: 2655688

Group type: EXPERIMENTAL
Intervention: ICI 169, 369 (10, 30, and 50 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 342302

Group type: EXPERIMENTAL
Intervention: Lunerin Mixture, Lunerin Mite
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0